The Wellness Industry Is Misleading You W/ Dr. Zeke Emanuel, Author, Eat Your Ice Cream
In this episode of CareTalk, Dr. Zeke Emanuel critiques the $1‑2 trillion wellness industry, arguing that it exploits the wealthy with dubious supplements, tests, and diets while neglecting timeless health fundamentals. He emphasizes that genuine wellness hinges on social connections—citing Aristotle, Hippocrates, and modern studies showing loneliness raises mortality risk as much as smoking. Emanuel also offers practical advice: prioritize walking, moderate exercise, and regular social interaction, and even defends dairy (especially ice cream) as a beneficial food when consumed responsibly. Throughout, he challenges elite longevity gurus for turning health into an obsessive goal rather than a balanced lifestyle.
Drug Dealin Ep. 9: Using AI to Find Novel Treatment Options
In Episode 9 of Drug Dealin, hosts Kenny and Shibu demonstrate how patients can use publicly available tools like ClinicalTrials.gov and AI language models to uncover novel treatment options, focusing on a hypothetical Parkinson’s disease case inspired by a TV...
Can AI Reduce Medical Errors?
The episode discusses the alarming rate of medical errors—estimated at 800,000 to a million deaths annually—and explores how AI can help reduce these mistakes. The host highlights personal experience using AI tools like OpenEvidence, GPT, and Gemini to obtain specialist-level...
Healthcare Before Medicare: Creating Your Own Action Plan
Roger Whitney concludes his four-part series on pre‑Medicare health care by introducing the OODA Loop—observe, orient, decide, act—as a practical decision framework. He walks listeners through building a five‑year cash‑flow plan, estimating MAGI, and assessing ACA subsidy eligibility alongside COBRA...
Reprogramming Cancer From Within
In this episode, Dr. Aaron Vinnie shares his journey from a leukemia survivor to a Columbia University hematology‑oncology researcher, advocating a shift from traditional cytotoxic chemotherapy to precision strategies that rewire malignant blood cells. He explains how hematologic cancers stem...
EqualityMD’s Pre-Insurance Strategy to Reduce Care Avoidance and Lower Healthcare Costs
In this episode, Unity Stokes chats with Justin Ayers, CEO of EqualityMD, about the company’s shift from a direct‑to‑consumer, membership model to a B2B/B2B2C platform that offers employers an insurance‑free telehealth solution with culturally competent clinicians and free prescriptions. Ayers...
Episode 59 - How Clinical Insight Drives Better Pharmacy Outcomes with Employers Health
In this episode, Kevin Wenceslau, Director of Clinical Solutions at Employers Health, explains how their clinical team uses evidence‑based insight to shape pharmacy benefit strategies for employers. He highlights their proactive utilization management—building custom clinical edits, collaborating with PBMs, and...
Sana Health Clears a Major Milestone in the Fight Against Chronic Pain
In this episode, Richard Hanbury of Sana Health discusses the company’s recent FDA De Novo clearance for a novel audio‑visual neuromodulation device targeting neuropathic pain, marking the creation of a new therapeutic class. He outlines decades of research that led...
AM Best’s Briefing – Health: Medicare Advantage – Challenges and Opportunities
The episode provides an overview of the current Medicare Advantage (MA) landscape, highlighting regulatory changes, enrollment trends, and financial pressures facing insurers. It examines challenges such as rising cost of care, tighter network requirements, and the impact of the Medicare...
Take Two: EP398: Why Are Commercial Carrier Marketplaces Completely Boring? Maybe Because There Isn't a Marketplace, With Jacob Asher, MD
In this episode of the "No Market" series, host Stacey Richter talks with Dr. Jacob Asher, a former chief medical officer for major health plans, about why commercial carrier marketplaces—especially in California—are stagnant and lack true competition. They identify six...
The Trust Problem With Healthcare AI
In this brief clip, host David Williams talks with Dr. Sarah Matt about the critical role of explainability in building trust for AI-driven healthcare. Dr. Matt emphasizes that patients and providers must understand how AI models make decisions to feel...
Healthcare Before Medicare: How to Lower Your Costs
In this third episode of his four‑part series, Roger Whitney guides listeners through practical ways to lower health‑care costs before Medicare, from daily health habits to smart insurance shopping. He demystifies the ACA premium subsidy system now that the expanded...
DDW Highlights: 17 February 2026
In this 16‑minute DDW Highlights episode, host Bruno Quinney recaps five major drug‑discovery stories from the past week, focusing on a breakthrough study linking specific biomarkers to improved cancer survival rates and the launch of a multinational consortium tackling chronic...
Newman Explains How Sanford Health Is Virtually Rewriting the Rural Health Playbook
Dave Newman, MD, Chief Medical Officer of Virtual Care at Sanford Health, explains how the system’s expansive virtual care program—spanning 78 specialties across 300,000 square miles—has become essential for rural patients, saving them an average of 176 miles per visit....
Learn the ABCs of Medicare, Ep293
In this episode Ryan Morrissey breaks down the essentials of Medicare for listeners approaching age 65, covering Parts A, B, C, and D, associated costs, and the critical timing of enrollment to avoid penalties. He explains the differences between original...
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
In this episode, a16z partner Jorge Conde interviews Novartis CEO Vasant Narasimhan about reshaping the 250‑year‑old conglomerate into a focused medicines company, a move he estimates will unlock $180 billion of value. Narasimhan outlines Novartis’s three platform pillars—cell and gene therapies,...
🎧 The GLP-1 Business Model Problem, Ep. 1 with Prof. Alex Miras
In the inaugural episode, host Alex discusses the GLP‑1 business model with obesity expert Prof. Alex Miras, who emphasizes that the drug itself drives the bulk of weight loss—about 20% versus 2.5% from behavioral support—making extensive multidisciplinary care unnecessary for...
Will AI Replace Doctors? A Conversation with Physician & NYT Bestselling Author Dr. Bob Wachter About the Digital vs Human...
In this live conversation, Dr. Bob Wachter and Dr. Lucy McBride discuss the fragmented state of electronic medical records (EMRs) and how patients and physicians alike are overwhelmed by multiple, non‑communicating digital portals. They highlight federal efforts to create standardized, interoperable...
Sami Inkinen of Virta Health on AI-Native Healthcare and Reversing Metabolic Disease
In this fireside chat, Sami Inkinen, CEO and founder of Virta Health, explains how his personal pre‑diabetes diagnosis inspired the creation of a company that uses nutrition, technology and AI to reverse type‑2 diabetes and obesity. He describes Virta’s massive...
Women in Science, Robotics, Automation, SLAS, and Lilly Updates
The episode opens with a celebration of Women in Science Day, highlighting the historic origin of the term “scientist” and the push for greater female leadership in biotech. Medra CEO Michelle Lee discusses how the company is merging robotics with...
EP500: This Is Episode 500, and It's All About You, Tribe
In episode 500 of the Relentless Health Value podcast, host Stacey Richter celebrates the community of healthcare entrepreneurs, executives, and change‑makers she calls the "tribe," highlighting how the show has moved listeners from theory to real‑world transformation. Listener clips illustrate...
🔬Beyond AlphaFold: How Boltz Is Open-Sourcing the Future of Drug Discovery
In this episode, Gabriele Corso and Jeremy Wohlwend discuss how structural biology has moved beyond AlphaFold's single‑chain predictions toward modeling complex interactions and generative protein design with their open‑source Boltz suite (Boltz‑1, Boltz‑2, and BoltzGen). They explain that evolutionary co‑variation...
Healthcare Before Medicare: Your Options
In this episode of The Retirement Answer Man, Roger Whitney walks listeners through the three primary health‑care options available before Medicare eligibility: COBRA continuation coverage, ACA marketplace plans, and part‑time employer group insurance, while also noting other alternatives like private...
A One Two Gene Therapy Punch to Non-Muscle Invasive Bladder Cancer
The episode explores EnGene's experimental gene therapy, detalimogene, for treating non‑muscle invasive bladder cancer, a condition affecting half a million new patients annually. Ron Cooper, EnGene's CEO, explains how the therapy uses a non‑viral vector to deliver a dual payload...
DDW Highlights: 10 February 2026
In this 15‑minute episode, DDW host Bruno Quinney recaps five major stories from the past week, highlighting breakthrough cancer therapies that promise greater efficacy and safety, and new research aimed at enhancing brain function in Alzheimer’s patients. He also touches...
Health First’s Carr Weaves Tapestry for Integrated Payer-Provider Platform
In this episode, Michael Carr, VP and CIO of Health First, discusses the organization’s integrated payer‑provider platform built on Epic’s suite, including the provider rollout and the Epic Tapestry health‑plan implementation. He highlights how consolidating nine disparate systems into a...
Why Exercise Beats Longevity Hacks W/ Dr. Jordan Metzl, Author, The Athlete's Book of Home Remedies
In this episode, host John Driscoll talks with sports‑medicine physician Dr. Jordan Metzl about why regular exercise is the most effective "drug" for extending healthspan, outpacing the myriad longevity supplements and hacks on the market. Dr. Metzl explains how strength...